BioStem Technologies (OTC: BSEM), a regenerative medicine company specializing in perinatal tissue allografts, has appointed Katherine Gorrell as Chief Legal & Compliance Officer, effective April 27, 2026. The announcement, made on April 30, 2026, underscores the company's commitment to strengthening its governance and compliance framework as it pursues a Nasdaq uplisting.
Ms. Gorrell brings over two decades of experience advising healthcare organizations on complex regulatory, transactional, and governance matters. She previously served as Vice President and General Counsel at Holy Cross Health in Fort Lauderdale, Florida, where she led legal strategy across a multi-faceted healthcare enterprise. Her career also includes roles as General Counsel and Compliance Officer at AdvancedMD, a national healthcare IT company, and in-house positions at Intermountain Healthcare and Providence Health & Services/Swedish Health Services. She holds a JD with Honors in Health Law from the University of Washington School of Law and a BA with Honors in Political Science from the University of Utah.
In her new role, Gorrell will oversee BioStem's legal and compliance functions and play a central role in enterprise governance, including the integration and oversight of Medical Affairs through the company's compliance framework. Jason Matuszewski, Chairman and CEO of BioStem, stated, 'Katherine is a key addition to BioStem as we implement our next phase of growth. Katherine brings a demonstrated ability to partner effectively with boards and executive teams, and her leadership will support our continued scaling while reinforcing our strong foundation of integrity and compliance, especially as we progress toward a Nasdaq uplisting.'
Gorrell commented, 'BioStem is at a pivotal time in its growth and evolution. I look forward to working with the leadership team and board to support sustainable growth, strengthen governance, and ensure our legal, compliance, and medical affairs functions continue to evolve with the business.'
BioStem Technologies leverages proprietary processing technologies including BioRetain®, CryoTek®, and SteriTek® to preserve the natural properties of perinatal tissues for clinical use. The company's products are used across a wide range of medical specialties, and its quality management system is accredited by the American Association of Tissue Banks. The latest news and updates relating to $BSEM are available in the company's newsroom at https://tinyurl.com/bsemnewsroom.
